Salivary changes and dental caries as potential oral markers of autoimmune salivary gland dysfunction in primary Sjögren's syndrome

BMC Clinical Pathology

Volumn 5, Issue , 2005, Pages

  Pedersen, Anne Marie Lynge ^a   Bardow, Allan ^a   Nauntofte, Birgitte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CHLORIDE; LA ANTIBODY; RO ANTIBODY; SODIUM;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENTAL CARIES; DIET; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; EATING HABIT; FEMALE; FLOW RATE; HUMAN; MOUTH HYGIENE; PAROTID GLAND; PATHOPHYSIOLOGY; PERIODONTICS; SALIVA ANALYSIS; SALIVA LEVEL; SALIVARY GLAND DISEASE; SALIVARY GLAND FUNCTION; SALIVATION; SCORING SYSTEM; SJOEGREN SYNDROME; SURFACE PROPERTY; TOOTH FILLING; XEROSTOMIA;

EID: 17844395702     PISSN: 14726890     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-5-4     Document Type: Article

References (53)

1. Moutsopoulos HM, Talal N: Immunological abnormalities in Sjögren's syndrome. In Sjögren's syndrome. Clinical and immunological aspects Edited by: Talal N, Moutsopoulos HM, Kassan SS. Heidelberg: Springer Verlag; 1987:258-265.
2. Pedersen AM, Nauntofte B: Primary Sjögren's syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy. Expert Opin Pharmacother 2001, 2:1415-1436.
3. Daniels TE, Silverman S, Michalski JP, Greenspan JS, Path MRC, Sylvester RA, Talal N: The oral component of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1975, 39:875-885.
4. Soto-Rojas AE, Villa AR, Sifuentes-Osornio J, Alarcon-Segovia D, Kraus A: Oral manifestations in patients with Sjögren's syndrome. J Rheumatol 1998, 25:906-910.
5. Pedersen AM, Reibel J, Nordgarden H, HO Bergem, Jensen JL, Nauntofte B: Primary Sjögren's syndrome: salivary gland function and clinical oral findings. Oral Dis 1999, 5:128-138.
6. Strömbeck B, Ekdahl C, Manthorpe R, Wikström I, Jacobsson L: Health-related quality of life in primary Sjögren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population using SF-36. Scand J Rheumatol 2000, 29:20-28.
7. Ravald N, List T: Caries and periodontal conditions in patients with primary Sjögren's syndrome. Swed Dent J 1998, 22:97-103.
8. Pedersen AM, Reibel J, Nauntofte B: Primary Sjögren's syndrome: subjective symptoms and salivary findings. J Oral Pathol Med 1999, 28:303-311.
9. Christensen LB, Petersen PE, Thorn JJ, Schiødt M: Dental caries and dental health behavior of patients with primary Sjögren's syndrome. Acta Odontol Scand 2001, 59:116-120.
10. Baudet-Pommel M, Albuisson E, Kemeny JL, Falvard F, Ristori JM, Fraysse MP, Sauvezie B.: Early dental loss in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1994, 78:181-186.
11. Almståhl A, Wikström M, Kroneld U: Microflora in oral ecosystems in primary Sjögren's syndrome. J Rheumatol 2001, 28:1007-1013.
12. Fejerskov O: Concepts of dental caries and their consequences for understanding the disease. Community Dent Oral Epidemiol 1997, 25:5-12.
13. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren's Syndrome: Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
14. Manthorpe R, Oxholm P, Prause JU, Schiødt M: The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol 1986:19-21.
15. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
16. 2. Arch Oral Biol 2000, 45:1-12.
17. Bardow A, Madsen J, Nauntofte B: The bicarbonate concentration in human saliva does not exceed the plasma level under normal physiological conditions. Clin Oral Invest 2000, 4:245-253.
18. Van Slyke DD: On the measurement of buffer values and on the relationship of buffer value to the dissociation constant of the buffer and the concentration and reaction of the buffer solution. J Biol Chem 1922, 52:525-570.
19. Schmidt-Nielsen B: The solubility of tooth substance in relation to the composition of saliva. In Thesis Copenhagen; 1946.
20. nd edition. Gerodontology 1997, 14:33-47.
21. Hunter KD, Wilson WS: The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva. Arch Oral Biol 1995, 40:983-989.
22. Nederfors T: Xerostomia: prevalence and pharmacotherapy. With special reference to beta-adrenoceptor antagonists. Swed Dent J 1996:1-70.
23. Manthorpe R, Benoni C, Jacobsson L, Kirtava Z, Larsson A, Liedholm R, Nyhagen C, Tabery H, Theander E: Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? Ann Rheum Dis 2000, 59:54-60.
24. Khan GJ, Mehmood R, Salah-ud-Din , Ihtesham-ul-Haq : Effects of long-term use of tobacco on taste receptors and salivary secretion. J Ayub Med Coll Abbottabad 2003, 15:37-39.
25. Workshop on diagnostic criteria for Sjögren's syndrome: Clinical Exp Rheumatol 1989, 7:212-219.
26. Boutsi EA, Paikos S, Dafni UG, Moutsopoulos HM, Skopouli FN: Dental and periodontal status of Sjögren's syndrome. J Clin Periodontol 2000, 27:231-235.
27. Bozkurt FY, Berker E, Akkus S, Bulut S: Relationship between interleukin-6 levels in gingival crevicular fluid and periodontal status in patients with rheumatoid arthritis and adult periodontitis. J Periodontol 2000, 71:1756-1760.
28. Almståhl A, Kroneld U, Tarkowski A, Wikström M: Oral microbial flora in Sjögren's syndrome. J Rheumatol 1999, 26:110-114.
29. Bardow A, Nyvad B, Nauntofte B: Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol 2001, 46:413-423.
30. Lundström IM, Lindström FD: Subjective and clinical oral symptoms in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 1995, 13:725-731.
31. Navazesh M, Wood GJ, Brightman V: Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995, 80:284-288.
32. Hausen H: Caries prediction - state of the art. Community Dent Oral Epidemiol 1997, 25:87-96.
33. Scheinin A, Pienihäkkinen K, Tiekso J, Holmberg S: Multifactorial modeling for root caries prediction. Community Dent Oral Epidemiol 1992, 20:35-37.
34. Lilienthal B: An analysis of the buffer systems in saliva. J Dent Res 1955, 34:516-530.
35. Izutsu KT, Madden PR: Evidence for the presence of carbamino compounds in human saliva. J Dent Res 1978, 57:319-325.
36. Helm JP, Dodds WJ, Hogan WJ, Soergel KH, Egide MS, Wood CM: Acid neutralizing capacity of human saliva. Gastroenterology 1982, 83:69-74.
37. Dawes C: Physiological factors affecting salivary flow rate, oral sugar clearance and the sensation of dry mouth in man. J Dent Res 1987, 66:648-53.
38. Sreebny LM, Banoczy J, Baum BJ, Edgar WM, Epstein JB, Fox PC: Saliva. The Working Group of the Commision on Oral Health, Research and Epidemiology (CORE). Féderation Dentaire Internationale. London: FDI World Dental Press; 1991.
39. Cook DI, Van Lennep EW, Roberts ML, Young JA: Secretion by the major salivary glands. In Physiology of the Gastrointestinal Tract Edited by: Johnson LR. New York: Raven Press; 1994:1061-1117.
40. Mandel ID, Baurmash H: Sialochemistry in Sjögren's syndrome. Oral Surg 1976, 41:182-187.
41. Atkinson JC, Travis WD, Pillemer SR, Wolff A, Bermudez D, Fox PC: Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical findings. J Rheumatol 1990, 17:318-322.
42. Kalk WW, Vissink A, Spijkervet FKL, Bootsma H, Nieuw Amerongen AV, Kallenberg CGM: Sialometry and sialochemistry: a noninvasive approach for diagnosing Sjögren's syndrome. Ann Rheum Dis 2002, 61:137-144.
43. Murer H, Biber J: [Molecular physiology and pathophysiology of renal phosphate excretion]. Schweiz Med Wochenschr 1998, 128:1247-1252. Article in German.
44. Thaysen JH, Thorn NA, Schwartz IL: Excretion of sodium, potassium, chloride and carbondiozide in human parotid saliva. Am J Physiol 1954, 178:155-159.
45. Stuchell RN, Mandel ID, Baurmash H: Clinical utilization of sialochemistry in Sjögren's syndrome. J Oral Pathol 1984, 13:303-309.
46. Nahir AM, Szargel R, Scharf Y: Chemical analysis of whole saliva in Sjögren's syndrome. Ann Rheum Dis 1987, 46:654-657.
47. Bowman SJ: Collaborative research into outcome measures in Sjögren's syndrome. Update on disease assessment. Scand J Rheumatol Suppl 2002, 116:23-27.
48. Pillemer SR, Smith J, Fox PC, Bowman SJ: Workshop Report: Outcome Measures for Sjögren's Syndrome, April 10-11, 2003, Bethesda, Maryland, USA. J Rheumatol 2005, 32:143-149.
49. Chisholm DM, Waterhouse JP, Mason DK: Lymphocytic sialoadenitis in the major and minor salivary glands: A correlation in post mortem subjects. J Clin Pathol 1970, 23:690-694.
50. Wise CM, Agudelo CA, Semble EL, Stump TE, Woodruff RD: Comparison of parotid and minor salivary gland biopsy specimens in the diagnosis of Sjögren's syndrome. Arthritis Rheum 1988, 31:662-666.
51. Ihrler S, Zietz C, Sendelhofert A, Lang S, Blasenbreu-Vogt S, Löhrs U: A morphogenetic concept of salivary duct regeneration and metaplasia. Virchows Arch 2002, 440:519-526.
52. 2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjögren's syndrome (pSS). J Oral Pathol Med 2000, 29:97-109.
53. Garty H, Palmer LG: Epithelial sodium channels: function, structure, and regulation. Physiol Rev 1997, 77:359-396.